Research Progress on the Role of Pyroptosis in Myocardial Ischemia-Reperfusion Injury

Myocardial ischemia-reperfusion injury (MIRI) results in the aggravation of myocardial injury caused by rapid recanalization of the ischemic myocardium. In the past few years, there is a growing interest in investigating the complex pathophysiological mechanism of MIRI for the identification of effective targets and drugs to alleviate MIRI. Currently, pyroptosis, a type of inflammatory programmed death, has received greater attention. It is involved in the MIRI development in combination with other mechanisms of MIRI, such as oxidative stress, calcium overload, necroptosis, and apoptosis, thereby forming an intertwined association between different pathways that affect MIRI by regulating common pathway molecules. This review describes the pyroptosis mechanism in MIRI and its relationship with other mechanisms, and also highlights non-coding RNAs and non-cardiomyocytes as regulators of cardiomyocyte pyroptosis by mediating associated pathways or proteins to participate in the initiation and development of MIRI. The research progress on novel small molecule drugs, clinical drugs, traditional Chinese medicine, etc. for regulating pyroptosis can play a crucial role in effective MIRI alleviation. When compared to research on other mature mechanisms, the research studies on pyroptosis in MIRI are inadequate. Although many related protective drugs have been identified, these drugs generally lack clinical applications. It is necessary to further explore and verify these drugs to expand their applications in clinical setting. Early inhibition of MIRI by targeted regulation of pyroptosis is a key concern that needs to be addressed in future studies.

Automated summary

Myocardial ischemia-reperfusion injury (MIRI) is the aggravation of myocardial injury caused by rapid recanalization of the ischemic myocardium. Pyroptosis, a type of inflammatory programmed death, plays a crucial role in MIRI development in combination with other mechanisms such as oxidative stress, calcium overload, necroptosis, and apoptosis. This review describes the mechanism of pyroptosis in MIRI and its relationship with other mechanisms, and highlights the involvement of non-coding RNAs and non-cardiomyocytes in regulating cardiomyocyte pyroptosis. Research progress on novel small molecule drugs, clinical drugs, and traditional Chinese medicine for regulating pyroptosis can greatly contribute to effective MIRI alleviation.